GlassScriptPhysician profile
Antonia Zecevic
NPI 1457713158
$6,501.81
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $3,000 · 2021: $3,000 · 2022: $30.21 · 2023: $131 · 2024: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $318.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,000.00 | 2020-2021 | |
| Medtronic USA, INC. | $92.71 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $64.47 | 2023 | Seglentis |
| Boston Scientific Corporation | $60.78 | 2019 | |
| Exact Sciences Corporation | $59.51 | 2023-2024 | Cologuard Collection Kit |
| Mayne Pharma Commercial LLC | $51.54 | 2024 | |
| Sumitomo Pharma America, INC. | $46.90 | 2023-2024 | Myfembree |
| Pfizer INC. | $43.64 | 2023-2024 | |
| Abbvie INC. | $30.21 | 2022 | |
| Coopersurgical, INC. | $19.39 | 2024 | Paragard T 380a |
| Organon LLC | $17.30 | 2024 | |
| Merck Sharp & Dohme LLC | $15.36 | 2024 | Gardasil 9, Gardasil |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonia Zecevic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.